Anupam Rasayan India Ltd.
NSE: ANURAS · Chemicals
Sector
Chemicals
Size band
Small cap
Market cap
14,143cr
P/E
90
ROE
2.7%
Dividend yield
0.1%
No price is shown on this page, live or delayed. It records what management said on the earnings call, and the company’s filings.
Measured against
Peer set
Speciality Chemicals · largest 12 of 32 measured at Q1 FY27 · financials via Screener| Company | Operating margin | Revenue growth |
|---|---|---|
| Gujarat Fluorochemicals Ltd. | 27.0% | 24.0% |
| Navin Fluorine International Ltd. | 34.0% | 44.1% |
| Atul Ltd. | 21.0% | 25.0% |
| Aarti Industries Ltd. | 16.0% | 42.5% |
| Aether Industries Ltd. | 31.0% | 27.2% |
| Anupam Rasayan India Ltd. | 25.0% | 34.8% |
| Vinati Organics Ltd. | 24.0% | 28.4% |
| Privi Speciality Chemicals Ltd. | 23.0% | 19.1% |
| Jubilant Ingrevia Ltd. | 15.0% | 25.2% |
| Clean Science And Technology Ltd. | 36.0% | 10.3% |
| Alkyl Amines Chemicals Ltd. | 25.0% | 30.0% |
| Epigral Ltd. | 25.0% | 16.1% |
What management said
8 statements on recordEarnings call · Q1 FY27 / quarter ended June 30, 2026 · 20 Aug 2026
- Consolidated EBITDA margin→22% to 24% EBITDA margin· next 2 to 3 years
“And on a consol basis, we should be looking at anything between 22% to 24% EBITDA margin is what I would really guide at because there are multiple companies, multiple segments, multiple end markets.”
- Standalone EBITDA margin→24% to 26%· next 2 to 3 years
“So typically, as I have been always guiding that on a standalone, we should be looking at anything between 24% to 26% on a standalone basis.”
- Polymer business contribution→20% to 25% standalone; 30% to 35% consolidated
“But we believe that on a standalone, we should be able to get a polymer business to be in the range of 20% to 25%. And on a consolidated basis, it should be in the range of 30% to 35%.”
- Capex→INR70 crores to INR80 crores· FY27 and FY28 / for now
“And to my mind, in the range of INR70 crores to INR80 crores may be the number that I would look at from a capex point of view, for now.”
- Revenue growth→25 plus or minus a couple of percentage points organic; another 10% to 15% additional growth from Jayhawk· FY27
“So if you see, what we had also mentioned earlier in our call and this also, we believe that the number will continue to be in the range of 25 plus or minus a couple of percentage points in terms of our revenue growth on an organic basis. And with the addition of the Jayhawk, that number will be added because Jayhawk was not counted in our last year's revenue, any significant revenue. So another 10% to 15% of additional growth will come because of the addition of Jayhawk's revenue line.”
- Order book revenue contribution→25% of revenue this year; around 30% going forward· this year and going forward
“This year, we are expecting it to be significantly higher, contributing around about 25% of our revenue. And going forward, it should contribute around 30%-odd of our revenue with the higher base volume that we have.”
- Bliss GVS capacity utilisation→60% to 70%· next 2 to 3 years
“So we continue to believe that we should be able to improve the utilization of the company's assets to 60% to 70%, and that would translate to the kind of numbers that are there, that would be there.”
- Debt for Bliss acquisition→around about INR300 crores
“There, we will be taking a debt of around about INR300 crores.”
Taken from management commentary on the company’s earnings call and quoted verbatim. These are statements of intent made by the company, not forecasts by Bharatstox, and nothing here records whether they were met.
On air
1 call · outcomes not trackedRecorded as stated on air, with the analyst's SEBI registration status where it was given. Anchor calls carry no registration and are marked. Bharatstox does not make, endorse or repeat these calls, and none of them is our view.
| Channel & show | Aired | Stated target | Stated stop | Outcome |
|---|---|---|---|---|
| NDTV ProfitNDTV Profit · no registration attached | 19 Aug | +11.2% | — | still open |
Shareholding
change across 4 filings| Category | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Change |
|---|---|---|---|---|---|
| Promoters | 59.1 | 59.1 | 59.1 | 59.1 | 0.0 |
| Foreign institutions | 7.7 | 6.9 | 7.6 | 7.6 | +0.1 |
| Domestic institutions | 0.4 | 0.4 | 0.4 | 1.4 | −1.0 |
| Retail & others | 32.8 | 33.7 | 32.9 | 31.9 | +0.9 |
As filed with the exchange for the periods ending Sep 25 to Jun 26.
Filings
latest 25 of 218- General Updates7 Sept 2026
- The Board of Directors of the Company at its meeting held on September 07, 2026, has approved the acquisition of equity shares in Tanfac Industries Limited pursuant to a preferential issue.7 Sept 2026
- Appointment7 Sept 2026
- The Board of Directors of the Company at its meeting held on September 07, 2026, has considered and approved the appointment of Ms. Hetvi Vyas as Chief Deputy Financial Officer and Key ....7 Sept 2026
- Record Date7 Sept 2026
- The Board of Directors of the Company at its meeting held on September 07, 2026, has approved and fixed the record date as Friday, September 18, 2026, for the payment of final dividend ....7 Sept 2026
- Outcome of Board Meeting7 Sept 2026
- Outcome of Board Meeting held on September 07, 2026.7 Sept 2026
- Copy of Newspaper Publication1 Sept 2026
- Submission of Newspaper Advertisement clippings pertaining to Post Offer Advertisement.1 Sept 2026
- Credit Rating31 Aug 2026
- The credit rating agency Crisil Ratings Limited has continued its ratings on the bank facilities and non-convertible debentures of the Company.31 Aug 2026
- Analysts/Institutional Investor Meet/Con. Call Updates20 Aug 2026
- Submission of transcript of earnings call on the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026.20 Aug 2026
- Analysts/Institutional Investor Meet/Con. Call Updates14 Aug 2026
- Investor Presentation14 Aug 2026
- Press Release14 Aug 2026
- Appointment14 Aug 2026
- Outcome of Board Meeting14 Aug 2026
- ESOP/ESOS/ESPS13 Aug 2026
- Analysts/Institutional Investor Meet/Con. Call Updates11 Aug 2026
- Copy of Newspaper Publication27 Jul 2026
- General Updates21 Jul 2026
- Submission of Letter of Offer regarding the open offer for acquisition of fully paid-up equity shares of Bliss GVS Pharma Limited from the Public Shareholders, by the Company together with PAC21 Jul 2026
- General Updates17 Jul 2026
The 25 most recent of 218 filings we hold for ANURAS, back to January 2024. Every filing, by day.
Disclaimer
Guidance is quoted from management commentary on quarterly earnings calls; the words are the company's own and the targets are theirs, not ours. Peer comparisons use quarterly financials sourced from Screener, with every company measured at the same fiscal quarter; the peer set is companies sharing the same industry classification, and comparisons are descriptive, not a ranking or a view. Broadcast calls are reproduced as stated on air, attributed, with the analyst's SEBI registration status where given; they are not our calls and not our view. Filings are reproduced as companies filed them to the NSE and BSE; Bharatstox does not verify, endorse or comment on their contents. This page is for informational and educational purposes only and does not constitute investment advice, research, or a recommendation to buy or sell any security. Investing in securities markets is subject to market risks. Read all related documents carefully before investing.